 abo antigen microglobulin transit cell carcinoma predictor respons intraves bacillu calmette-guerin respons patient superfici transit cell carcinoma bladder stcb intraves chemotherapi variabl patient long period recurr other recurr tumor year remov primari lesion other loss normal cell surfac antigen abo blood group microglobulin aggress behavior tumor studi immunohistochem techniqu author initi pretreat biopsi specimen bladder tumor presenc abo antigen data sampl patient popul biopsy-proven stcb express marker predict therapeut respons prophylact intraves bacillu calmette-guerin bcg tice strain resect express marker predict valu express antigen